A team of engineers at the University of California San Diego and La Jolla-based startup Nanovision Biosciences Inc. have developed the first nanoengineered retinal prosthesis — a step closer to restoring the ability of neurons in the retina to respond to light.
The technology could help tens of millions of people worldwide suffering from neurodegenerative diseases that affect eyesight, including macular degeneration, retinitis pigmentosa, and loss of vision due to diabetes.
